Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: A systematic review
Số trang: 14
Loại file: pdf
Dung lượng: 1.87 MB
Lượt xem: 11
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
There are differences in the pharmacoeconomics of Immune checkpoint blocking (ICB) therapies for the treatment of lung squamous cell carcinoma (LSCC). However, no corresponding review studies have fully discussed the cost-effectiveness of ICBs in treating LSCC. The aim of this paper is to systematically review and evaluate all available pharmacoeconomic studies of ICBs for LSCC.
Nội dung trích xuất từ tài liệu:
Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: A systematic review
Nội dung trích xuất từ tài liệu:
Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: A systematic review
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Cost-effectiveness Non-small cell lung cancer Immune checkpoint blocking Lung squamous cell carcinomaTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
13 trang 38 0 0